The introduction of nicotinamide being a nicotine substitute in e-cigarette and smokeless items signifies a substantial regulatory challenge with the FDA. Nicotinamide does not have nicotinic receptor agonist action and is known to act as a sedative at superior dosages6. The claims created by Nicoti